Answers are grounded in this paper and cite their sources.
Background: The clinical circumstances surrounding intrauterine balloon tamponade (IUBT) use in maternal deaths due to critical obstetric hemorrhage remain unclear.This study aimed to characterize maternal death cases in which IUBT was performed.Methods: This retrospective, nationwide, registry-based study analyzed maternal death cases reported to the Japan Association of Obstetricians and Gynecologists between 2010 and 2023.Cases in which critical obstetric hemorrhage was the primary cause of death and IUBT had been performed were included.Maternal characteristics, maternal status at IUBT placement, transfusion support, subsequent management, and the interval from IUBT placement to the decision for subsequent management were evaluated.Results: Among 590 maternal deaths, 104 were attributed to critical obstetric hemorrhage, and IUBT was performed in 20.Most patients had hemorrhagic shock and coagulopathy at IUBT placement, with massive blood loss, profound anemia, and severe hypofibrinogenemia.The main causes were amniotic fluid embolism with severe coagulopathy (n=12), placental abruption (n=5), and placenta accreta spectrum (n=2), conditions for which IUBT alone is unlikely to achieve definitive hemostasis.The decision for subsequent management was made more than 30 min after IUBT in 5 of the 11 evaluable patients.Among 14 women who underwent maternal transfer, transcatheter arterial embolization, or hysterectomy, transfusion had been initiated before the decision for subsequent management in nine patients.Conclusion: IUBT was frequently used as one of the few available interventions in extremely severe clinical situations.Although these findings do not necessarily indicate that the timing of management contributed to maternal death, the decision for subsequent management was made more than 30 min after IUBT in approximately half of the evaluable patients.These findings highlight the importance of recognizing IUBT as a temporizing intervention within the broader management of critical obstetric hemorrhage.
No takes yet. Share an insight, caveat, or question.
Ogoyama et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: